RxDoctor Payments Data

Kelci Minemyer

Family · Centennial, CONPI 1598372278

Payments from drug & device makers

$223in general payments, 2019–2025

Across 12 payments — averaging $18.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$31
  • Abiomed$30
  • Sanofi-aventis U.S. LLC$28
  • Amneal Pharmaceuticals LLC$25
  • Astellas Pharma US Inc$25
  • Novo Nordisk$24
  • plus $61 from 4 others

What the payments were for

  • Food & beverage$223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$223 in reported general payments places this provider in the 50th percentile of 2,182 family providers in Colorado.

See all family providers in Colorado

Medicare billing

Part B allowed, 2024
$20,581
Medicare patients
123
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$79,346
OzempicSemaglutide31$41,617
TrulicityDulaglutide14$27,387
XareltoRivaroxaban23$26,208
MounjaroTirzepatide16$20,236
JanuviaSitagliptin Phosphate21$19,184
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$16,002
MyrbetriqMirabegron11$15,247
Arnuity ElliptaFluticasone Furoate21$11,429
Advair HfaFluticasone Propion/Salmeterol14$7,333
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$4,142
SynthroidLevothyroxine Sodium48$3,055
Fluticasone-SalmeterolFluticasone Propion/Salmeterol33$3,031
Omeprazole127$3,008
Rosuvastatin Calcium230$2,956

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$24$41,61731 claims
Astellas Pharma US IncMyrbetriq$25$15,24711 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$25$2,512224 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,182 family providers in Colorado.

Other family in Centennial

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →